Stablix to Present at Wells Fargo 2023 Targeted Protein Degradation Summit
17 févr. 2023 07h00 HE
|
Stablix, Inc.
NEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Kevin...
Stablix Appoints Douglas Williams, Ph.D., to Board of Directors
18 janv. 2023 07h00 HE
|
Stablix, Inc.
NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced the...